MediWound (MDWD) EBIT Margin (2014 - 2025)

MediWound's (MDWD) quarterly EBIT Margin came in at 417.78% in Q4 2025, down 31331.0% year-on-year from N/an in Q4 2024, and down 247.61% quarter-over-quarter from 120.19% in Q3 2025.

MediWound (MDWD) EBIT Margin (2014 - 2025) Analysis & Trends

MediWound's EBIT Margin history runs 12 years deep, the most recent figure standing at 417.78% for Q4 2025.

  • On a quarterly basis, EBIT Margin fell 31331.0% year-over-year to 417.78% in Q4 2025; TTM through Dec 2025 was 194.28%, a 7823.0% decrease from a year earlier, with the FY2025 full-year figure at 148.98%, down 5305.0% from the prior year.
  • EBIT Margin eased to 417.78% in Q4 2025 per MDWD's latest filing, from 120.19% in the prior quarter.
  • Across five years, EBIT Margin topped out at 18.27% in Q4 2022 and bottomed at 417.78% in Q4 2025.
  • The 5-year median for EBIT Margin is 111.82% (2021), against an average of 143.23%.
  • Across the five-year window, EBIT Margin jumped 15204 bps in 2021 and tumbled 31331 bps in 2025, its largest moves.
  • Year by year, EBIT Margin stood at 64.17% in 2021, then jumped by 128 bps to 18.27% in 2022, then plunged by 499 bps to 72.95% in 2023, then slumped by 43 bps to 104.47% in 2024, then sank by 300 bps to 417.78% in 2025.
  • Per Business Quant, the three latest MDWD EBIT Margin figures stand at 417.78% (Q4 2025), 120.19% (Q3 2025), and 325.88% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 16.51%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 38.10%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 17.83%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 31.68%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 MediWound 183.16 Mn 178.36 Mn 278,000.00 -417.78%

Historic Data

Download Data
DateValue
Dec 31, 2025 -417.78%
Sep 30, 2025 -120.19%
Jun 30, 2025 -325.88%
Mar 31, 2025 -132.11%
Dec 31, 2024 -104.47%
Sep 30, 2024 -116.67%
Jun 30, 2024 -287.80%
Mar 31, 2024 -75.22%
Dec 31, 2023 -72.95%
Sep 30, 2023 -63.34%
Jun 30, 2023 -332.26%
Mar 31, 2023 -114.87%
Dec 31, 2022 18.27%
Sep 30, 2022 -60.49%
Jun 30, 2022 -220.13%
Mar 31, 2022 -74.52%
Dec 31, 2021 -64.17%
Sep 30, 2021 -109.08%
Jun 30, 2021 -114.56%
Mar 31, 2021 -76.29%